Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 1—January 2011
Dispatch

Serologic Status for Pandemic (H1N1) 2009 Virus, Taiwan

Daniel Tsung-Ning Huang1, Pei-Lan Shao1, Kuo-Chin Huang, Chun-Yi Lu, Jen-Ren Wang, Shin-Ru Shih, Hsin Chi, Mei-Ru Lai, Chin-Yun Lee, Luan-Yin Chang, and Li-Min HuangComments to Author 
Author affiliations: Author affiliations: Mackay Memorial Hospital, Taipei, Taiwan (D.T.-N. Huang, H. Chi); National Taiwan University Hospital, Taipei (P.-L. Shao, K.-C. Huang, C.-Y. Lu, M.-R. Lai, C.-Y. Lee, L.-Y. Chang, L.-M. Huang); National Cheng Kung University, Tainan, Taiwan (J.-R. Wang); Chang-Gung Memorial Hospital, Taipei (S.-R. Shih); National Taiwan University, Taipei (L.-M. Huang)

Main Article

Figure

Seroprotection rates determined by hemagglutination inhibition (HI) assay (white bars) or microneutralization (MN) assay (gray bars) and geometric mean titer (GMT) of antibodies against pandemic (H1N1) 2009 virus in each 10-year age cohort, Taiwan, 2007–2008.

Figure. Seroprotection rates determined by hemagglutination inhibition (HI) assay (white bars) or microneutralization (MN) assay (gray bars) and geometric mean titer (GMT) of antibodies against pandemic (H1N1) 2009 virus in each 10-year age cohort, Taiwan, 2007–2008.

Main Article

1These authors contributed equally to this article.

Page created: June 30, 2011
Page updated: June 30, 2011
Page reviewed: June 30, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external